Based on the application , the global digital pathology market is broadly segmented into disease diagnosis ; teleconsultation ; drug discovery ; and education & training . The teleconsultation application segment is estimated to account for the largest share of the global digital pathology market in 2016 . Additionally , this segment is projected to grow at the highest CAGR .
On the basis of region , the global market is divided into North America , Europe , Asia-Pacific , and the Rest of the World ( RoW ). In 2016 , North America is estimated to account for the largest share of the global digital pathology market , followed by Europe , Asia-Pacific , and the Rest of the World . The Asia-Pacific market is slated to grow at the highest CAGR and serve as a revenue pocket for companies offering digital pathology .
Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH ( Germany ), Ventana Medical Systems , Inc . ( U . S .), Hamamatsu Photonics K . K ( Japan ), 3D Histech Ltd . ( Hungary ), Philips Healthcare ( Netherlands ), Apollo Enterprise Imaging Corp . ( U . S .), Xifin , Inc . ( U . S .), Definiens AG ( Germany ), Visiopharm A / S ( Denmark ), Omnyx LLC ( U . S .), Corista LLC ( U . S .).
Download Sample Brochure